JEA BizDev Consulting, LLC®

Find your next opportunity.

HomeConnecting science. Creating value.PagesServicesExpertise across the BD value chainPagesAbout JohnExperience behind the partnershipsPagesOur approachFrom strategy to signed agreementPagesOpportunitiesExplore assets for partneringPagesTrack recordPartnerships and downloadable deal summariesPagesStart a conversationDiscuss an opportunity with JohnPagesMy cross-border dealsJEA reference library on Google DriveTransactionsCross-border deal libraryJEA reference library on Google DriveTransactionsDLL3 ADCOncology · IND Filing · DLL3AssetsHER2 Biparatopic ADCOncology · Phase 3 · HER2AssetsFRα Biparatopic ADCOncology · IND Filing · FRαAssetsCYP11B2 InhibitorCardiovascular · IND Filing · CYP11B2AssetsENPP1 InhibitorCardiovascular · IND Approved · ENPP1AssetsB7-H3 ADCOncology · Phase 1 · B7-H3AssetsATM InhibitorOncology · Phase 1 · ATMAssetsKAT6 InhibitorOncology · Phase 1 · KAT6A / KAT6BAssetsEGFR-ADCOncology · Phase 3 · EGFRAssetsNovaRock × Bionyra (2026)Exclusive license agreement for NBL-023, a novel anti–IL-25 monoclonal antibody, granting worldwide rights outside Greater China.TransactionsNovaRock × LigaChemBio (2026)Global out-licensing agreement for an ADC candidate targeting a novel oncology antigen.TransactionsCSPC × Radiance Biopharma (2025)$1,240 million strategic partnership for ROR1-ADC (SYS6005).TransactionsCSPC × Cipla (2025)$1,065 million strategic partnership for an Irinotecan Liposomal Injection product.TransactionsNovaRock × LigaChemBio (2025)Two global out-licensing agreements for novel antibodies.Transactions

OUR APPROACH

Shared ambition.

Every successful partnership starts with understanding what matters. We bring structure, perspective, and momentum to the decisions ahead.

01

Align on the ambition

Understand your science, portfolio, and commercial priorities. Define what a successful partnership needs to achieve.

02

Find the right fit

Identify and evaluate prospective partners across North America, Europe, and Asia. Build a focused outreach strategy.

03

Shape the partnership

Coordinate diligence, benchmark alternatives, and structure terms around shared value and clear responsibilities.

04

Execute with confidence

Support negotiation and closure, then establish the foundations for a productive alliance.

WHAT GUIDES THE WORK

Principles with
practical purpose.

Strategic collaboration

Meaningful connections and shared priorities are the foundations of productive, lasting partnerships.

Innovative solutions

Thoughtful, creative deal structures open new paths to value for both sides of the table.

A focus on results

Clear objectives and tangible outcomes keep the work connected to your company’s success.

WORKING TOGETHER

Support that fits your priorities.

A LITTLE MORE CLARITY

Before we
get started.

Have another question?
Who does JEA work with?

Biotech and biopharma companies seeking strategic guidance, in- or out-licensing opportunities, and support across the business development value chain.

Do you support cross-border partnerships?

Yes. JEA specializes in identifying, structuring, negotiating, and executing partnerships across North America, Europe, and Asia.

Can we engage you for one part of a transaction?

Yes. Engagements can cover targeted strategic advice, partner identification, due diligence, deal structuring, negotiation, or the full partnering process.

How are engagements structured?

Hourly, retainer, project-based, and blended models are available. Scope, deliverables, and commercial terms are discussed directly for each engagement.

How can I learn more about an available asset?

Browse the opportunities library and request an overview deck from an asset page. Current availability and development status should be confirmed directly with JEA.

What should I share in an initial inquiry?

Your company, the type of support you need, relevant territories, and your timeline are a useful starting point. Keep the first introduction non-confidential.

THE NEXT CONVERSATION COULD CHANGE EVERYTHING

Great science deserves
the right partnership.

Let’s talk about where you want to go,
and how we can help you get there.

Start a conversation